Adipose tissue macrophages (ATMs) have been demonstrated to convert from anti-inflammatory M2 phase to pro-inflammatory M1 type in diabetes conditions, and release the pro-inflammatory cytokines such as TNF-α, IL-6) and IL-12 (43, 177, 178). Here, IL6 is linked to diabetes mellitus.